Gut bacteria and health foods - The European perspective

International Journal of Food Microbiology

Volumn 78, Issue 1-2, 2002, Pages 99-117

  Saarela, M ^a   Lahteenmaki L ^a   Crittenden, R ^b   Salminen, S ^c   Mattila Sandholm, T ^a  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b DEFENCE SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Allergy; Arthritis; Chronic diseases; Consumer; Diarrhoea; European research; GI tract; Health effects; IBD; IBS; Indigenous microbiota; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ARTHRITIS; ATOPY; AUSTRALIA; BACTERIUM; CONSUMER; DISEASE ASSOCIATION; ENTERITIS; ENTEROPATHY; EUROPE; FOOD ALLERGY; FOOD ANALYSIS; FOOD INDUSTRY; GASTROINTESTINAL TRACT; HEALTH FOOD; HUMAN; INFECTION; INTESTINE FLORA; IRRITABLE COLON; JAPAN; MOLECULAR BIOLOGY; NONHUMAN; NUTRITIONAL SCIENCE; RESEARCH; REVIEW; SAFETY; WELLBEING; DIGESTIVE SYSTEM; GASTROINTESTINAL DISEASE; HEALTH PROMOTION; MICROBIOLOGY; TREATMENT OUTCOME;

MICROBIOTA;

DIGESTIVE SYSTEM; EUROPE; GASTROINTESTINAL DISEASES; HEALTH FOOD; HEALTH PROMOTION; HUMANS; PROBIOTICS; SAFETY; TREATMENT OUTCOME;

EID: 0037104991     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1605(02)00235-0     Document Type: Article

References (122)

1. Probiotic agents and infectious diseases: A modern perspective on a traditional therapy
2. Putting back the bugs: Bacterial treatment relieves chronic constipation and symptoms of irritable bowel disease
3. Predicting the intent to purchase unfamiliar and familiar cheeses: The effects of attitudes, expected liking and food neophobia
4. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study
5. The fecal microbial population in the irritable bowel syndrome
6. Beneficial effects of administration of Lactobacillus acidophilus in diarrheal and other intestinal disorders
7. Development of intestinal microflora in humans and animals
8. The indigenous gastrointestinal microflora
9. The intestinal microflora in allergic Estonian and Swedish 2-year-old children
10. Allergy development and the intestinal microflora during the first year of life
11. Bowel-flora alteration: A potential cure for inflammatory bowel disease and irritable bowel syndrome?
12. Instability in the faecal flora of a patient suffering from food related irritable bowel syndrome
13. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea
14. Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants
15. Management of the irritable bowel syndrome
16. Treatment of acute infantile diarrhea: Controlled trial of Saccharomyces boulardii (article in French)
17. Can immunoregulatory lactic acid bacteria be used as dietary supplement to limit allergies?
18. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: A review of papers published between 1988 and 1998
19. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
20. Probiotics: From myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials
21. Interactions between nutrition and intestinal microflora
22. Effect of diet on human fecal flora: Comparison of Japanese and American diets
23. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16 S rRNA-targeted oligonucleotide probes
24. Consumer attitudes towards different food-processing technologies used in cheese production - The influence of consumer benefit
25. Probiotics in man and animals
26. Paraghurt for patients with irritable bowel syndrome
27. Immunological aspects of host/microbiota interactions at the intestinal epithelium
28. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics
29. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
30. Fecal microflora in healthy infants born by different methods of delivery: Permanent changes in intestinal flora after cesarean delivery
31. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: A prospective follow up study of healthy infants aged 0-6 months
32. Three issues in consumer quality perception and acceptance of dairy products
33. Lactobacillus GG administered in oral solution to children with acute diarrhea: A multicenter European trial
34. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea
35. Is Lactobacillus GG helpful in children with Crohn's disease? Results of preliminary, open-label study
36. Intestinal gas production from bacterial fermentation of undigested carbohydrate in irritable bowel syndrome
37. Treatment of irritable bowel syndrome with Lacteol Fort: A randomized, double-blind, cross-over trial
38. Effect of long term consumption of probiotic milk on infections in children attending day care centers: Double blind, randomised trial
39. Are intestinal bacteria involved in the etiology of rheumatoid arthritis?
40. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants
41. Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors
42. Efficacy of Lactobacillus GG as a diarrheal preventive in travellers
43. Current concepts: The irritable bowel syndrome
44. Oral bacteriotherapy for viral gastroenteritis
45. New functional foods in the treatment of food allergy
46. Probiotics in the management of atopic excema
47. Probiotics: Effects on immunity
48. Role of probiotics in food hypersensitivity
49. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection
50. Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease
51. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing
52. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial
53. Lactobacilli to prevent traveler's diarrhea?
54. Probiotics: Potential pharmaceutic applications
55. Promotion of favorable gut flora in inflammatory bowel disease
56. Abnormal colonic fermentation in irritable bowel syndrome
57. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease
58. Aberrant composition of gut microbiota of allergic infants: A target of bifidobacterial therapy at weaning?
59. Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants
60. Prevention of traveller's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study (article in German)
61. Prophylactic and therapeutic uses of probiotics: A review
62. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
63. Food neophobia and variety seeking - Consumer fear or demand for new food products
64. A pan-European survey of consumers attitudes to food, nutrition and health: An overview
65. Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria
66. Motivation, cognition and pseudoscience
67. Probiotics: A novel approach in the management of food allergy
68. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis
69. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG
70. Protection from gastrointestinal diseases with the use of probiotics
71. Comparative study of bacterial groups within the human cecal and fecal microbiota
72. Probiotic functional foods
73. Probiotics: Towards demonstrating efficacy
74. The food, GI-tract functionality and human health cluster
75. Human fecal flora: The normal flora of 20 Japanese-Hawaiians
76. Uncooked, lactobacilli-rich vegan food and rheumatoid arthritis
77. A controlled double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome
78. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome
79. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children
80. Prevention of travellers' diarrhoea by Lactobacillus GG
81. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study
82. Differences in Bifidobacterium flora composition in allergic and healthy infants
83. Probiotics: A review of human studies to date and methodological approaches
84. Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet
85. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG
86. How do bacteria cause chronic arthritis?
87. Clinical and bacteriological studies of a new Lactobacillus acidophilus concentrate in functional gastrointestinal disturbances
88. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan
89. Non-pathogenic Esherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial
90. Quantification of consumer attitudes to health and hedonic characteristics of foods
91. Human food selection: The interaction of biology, culture and individual experience
92. Probiotic bacteria: Safety, functional and technological properties
93. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus
94. Impression of functional food consumers
95. Gut flora in normal and disordered states
96. Functional food science and gastrointestinal physiology and function
97. Demonstration of safety of probiotics - A review
98. Prevention and treatment of traveller's diarrhea: A clinical pharmacological approach
99. Probiotics and inflammatory bowel diseases
100. Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats
101. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization
102. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children
103. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis
104. Probiotic treatment using Bifidobacterium lactis HN109 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model
105. Effect of Lactobacillus GG yogurt in prevention of antibiotic associated diarrhea
106. Bacterial cell wall-induced arthritis: Chemical composition and tissue distribution of four Lactobacillus strains
107. The top ten functional food trends
108. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut
109. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii. A prospective study
110. Taste or health: A study on consumer acceptance of corn chips
111. Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis
112. Impact of dietary yogurt on immune function
113. Immune and clinical impact of Lactobacillus acidophilus on asthma
114. Lactobacillus acidophilus tablets in the therapy of functional intestinal disorders
115. Acquistion and extinction of flavour preferences conditioned by caffeine in humans